[et_pb_section fb_built=”1″ _builder_version=”4.24.2″ _module_preset=”default” background_image=”https:\/\/www.utopiasis.it\/wp-content\/uploads\/2024\/02\/experiment-biotechnology-with-chemistry-science-scaled.jpg” background_enable_mask_style=”on” background_mask_style=”caret” background_mask_color=”gcid-237e273c-f56a-4eda-aaac-e80fb41a0548″ custom_margin=”85px||||false|false” global_colors_info=”{%22gcid-237e273c-f56a-4eda-aaac-e80fb41a0548%22:%91%22background_mask_color%22%93}”][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_heading title=”Antonio Lanzavecchia” _builder_version=”4.27.5″ _module_preset=”default” title_text_color=”#FFFFFF” title_font_size=”40px” custom_margin=”||0px||false|false” global_colors_info=”{}”][\/et_pb_heading][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_row column_structure=”1_4,3_4″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/www.utopiasis.it\/wp-content\/uploads\/2026\/01\/3.png” title_text=”3″ _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”3_4″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.5″ _module_preset=”default” text_text_color=”#000000″ text_font_size=”17px” text_line_height=”1.8em” text_orientation=”justified” hover_enabled=”0″ locked=”off” global_colors_info=”{}” sticky_enabled=”0″]Antonio Lanzavecchia is renowned for his work on antigen presentation processes, T-cell activation, immunological memory, and for his studies on human monoclonal antibodies. He earned his medical degree at the University of Pavia, where he specialized in pediatrics and infectious diseases. Since 1983, he has worked in Switzerland, initially as a member of the Basel Institute for Immunology and, since 2000, as the founder and director of the Institute for Research in Biomedicine in Bellinzona.<\/p>\n
Lanzavecchia has served as Professor of Immunology at the University of Genoa, the University of Siena, and the Swiss Federal Institute of Technology (ETH Zurich). He is a member of EMBO and the Royal College of Physicians, and an honorary member of the American Society of Immunology, the Swiss Society of Immunology, and the Swiss Academy of Medical Sciences. He has received the EMBO Gold Medal, the Clo\u00ebtta Prize, the Robert Koch Prize, the Sanofi\u2013Institut Pasteur Prize, and the Louis-Jeantet Prize for Medicine.<\/p>\n
Lanzavecchia is the scientific founder of Humabs Biomed, now a subsidiary of Vir Biotechnology, and is currently a Senior Researcher at Vir Biotechnology. His academic research activities continue at INGM.[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"
Antonio Lanzavecchia is renowned for his work on antigen presentation processes, T-cell activation, immunological memory, and for his studies on human monoclonal antibodies. He earned his medical degree at the University of Pavia, where he specialized in pediatrics and infectious diseases. Since 1983, he has worked in Switzerland, initially as a member of the Basel […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"[et_pb_section fb_built=\"1\" _builder_version=\"4.24.2\" _module_preset=\"default\" background_image=\"https:\/\/www.utopiasis.it\/wp-content\/uploads\/2024\/02\/experiment-biotechnology-with-chemistry-science-scaled.jpg\" background_enable_mask_style=\"on\" background_mask_style=\"caret\" background_mask_color=\"gcid-237e273c-f56a-4eda-aaac-e80fb41a0548\" custom_margin=\"85px||||false|false\" global_colors_info=\"{%22gcid-237e273c-f56a-4eda-aaac-e80fb41a0548%22:%91%22background_mask_color%22%93}\" theme_builder_area=\"post_content\"][et_pb_row column_structure=\"1_2,1_2\" _builder_version=\"4.24.2\" _module_preset=\"default\" global_colors_info=\"{}\" theme_builder_area=\"post_content\"][et_pb_column type=\"1_2\" _builder_version=\"4.24.2\" _module_preset=\"default\" global_colors_info=\"{}\" theme_builder_area=\"post_content\"][et_pb_heading title=\"Antonio Lanzavecchia\" _builder_version=\"4.27.5\" _module_preset=\"default\" title_text_color=\"#FFFFFF\" title_font_size=\"40px\" custom_margin=\"||0px||false|false\" hover_enabled=\"0\" global_colors_info=\"{}\" theme_builder_area=\"post_content\" sticky_enabled=\"0\"][\/et_pb_heading][\/et_pb_column][et_pb_column type=\"1_2\" _builder_version=\"4.24.2\" _module_preset=\"default\" global_colors_info=\"{}\" theme_builder_area=\"post_content\"][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\"1\" _builder_version=\"4.24.2\" _module_preset=\"default\" global_colors_info=\"{}\" theme_builder_area=\"post_content\"][et_pb_row column_structure=\"1_4,3_4\" _builder_version=\"4.24.2\" _module_preset=\"default\" global_colors_info=\"{}\" theme_builder_area=\"post_content\"][et_pb_column type=\"1_4\" _builder_version=\"4.24.2\" _module_preset=\"default\" global_colors_info=\"{}\" theme_builder_area=\"post_content\"][et_pb_image src=\"https:\/\/www.utopiasis.it\/wp-content\/uploads\/2026\/01\/3.png\" title_text=\"3\" _builder_version=\"4.27.5\" _module_preset=\"default\" hover_enabled=\"0\" global_colors_info=\"{}\" theme_builder_area=\"post_content\" sticky_enabled=\"0\"][\/et_pb_image][\/et_pb_column][et_pb_column type=\"3_4\" _builder_version=\"4.24.2\" _module_preset=\"default\" global_colors_info=\"{}\" theme_builder_area=\"post_content\"][et_pb_text _builder_version=\"4.27.5\" _module_preset=\"default\" text_text_color=\"#000000\" text_font_size=\"17px\" text_line_height=\"1.8em\" text_orientation=\"justified\" hover_enabled=\"0\" locked=\"off\" global_colors_info=\"{}\" theme_builder_area=\"post_content\" sticky_enabled=\"0\"]Antonio Lanzavecchia \u00e8 noto per il suo lavoro sui processi di presentazione dell\u2019antigene, attivazione dei linfociti T, sulla memoria immunologica e per gli studi su anticorpi monoclonali umani. Lanzavecchia ha conseguito la laurea in medicina presso l\u2019Universit\u00e0 di Pavia, dove si \u00e8 specializzato in pediatria e malattie infettive. Dal 1983 lavora in Svizzera, inizialmente come membro dell\u2019Istituto di Immunologia di Basilea e dal 2000 come fondatore e direttore dell\u2019Istituto per la Ricerca in Biomedicina a Bellinzona.\n\nLanzavecchia \u00e8 stato professore di Immunologia all\u2019Universit\u00e0 di Genova e all\u2019Universit\u00e0 di Siena e al Politecnico federale ETH di Zurigo. \u00c8 membro di EMBO, del Royal College of Physicians e membro onorario dell\u2019American Society of Immunology, della Societ\u00e0 Svizzera di Immunologia e dell\u2019Accademia svizzera delle Scienze Mediche. Ha ricevuto la Medaglia d\u2019oro da EMBO, il premio Clo\u00ebtta, il premio Robert Koch, il premio Sanofi-Institut Pasteur e il premio Louis-Jeantet per la medicina.\n\nLanzavecchia \u00e8 il fondatore scientifico di Humabs Biomed, ora filiale di Vir Biotechnology, ed \u00e8 attualmente ricercatore senior presso Vir Biotechnology. L\u2019attivit\u00e0 di ricerca accademica continua invece presso INGM.[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]","_et_gb_content_width":"","footnotes":""},"class_list":["post-1414","page","type-page","status-publish","hentry"],"yoast_head":"\n